We are live on !
Find out more
Empowered Funds Portfolio holdings
AUM
$19B
Turnover
18.36%
1-Year Est. Return
51.72%
This Fund
S&P 500
This Quarter Est. Return
+24.74%
1 Year Est. Return
+51.72%
3 Year Est. Return
+126.89%
5 Year Est. Return
+174.8%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$3.32B
(+21%)
Cap. Flow
+$1.12B
Cap. Flow % of AUM
Cap. Flow %
5.9%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
2,320
New
218
Increased
1,053
Reduced
749
Closed
208
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$264M |
| 2 |
NVIDIA
NVDA
|
+$64.6M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$57.4M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$56M |
| 5 |
Citigroup
C
|
+$53.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41M |
| 2 |
iShares Global 100 ETF
IOO
|
+$28.4M |
| 3 |
Parker-Hannifin
PH
|
+$27.2M |
| 4 |
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
|
+$26.4M |
| 5 |
Kratos Defense & Security Solutions
KTOS
|
+$25.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.19% |
| 2 | Financials | 12.41% |
| 3 | Consumer Discretionary | 10.11% |
| 4 | Miscellaneous | 10.04% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Conduent
CNDT
$264M
| $286K | ﹤0.01% |
195,802
-375,000
| -66% | -$582K |
2026 Q1
1 quarter
|
|
1877
NRC Health Common Stock
NRC
$497M
| $285K | ﹤0.01% |
13,198
-84
| -0.6% | -$1.56K |
2026 Q1
1 quarter
|
|
1878
Euronet Worldwide
EEFT
$2.39B
| $284K | ﹤0.01% |
+3,881
| New | +$271K |
2026 Q2
0 quarters
|
|
1879
Plexus
PLXS
$5.93B
| $284K | ﹤0.01% |
+944
| New | +$246K |
2026 Q2
0 quarters
|
|
1880
Vornado Realty Trust
VNO
$6.5B
| $282K | ﹤0.01% |
7,165
-5,181
| -42% | -$167K |
2026 Q1
1 quarter
|
|
1881
MYR Group
MYRG
$4.06B
| $281K | ﹤0.01% |
561
-1,379
| -71% | -$566K |
2026 Q1
1 quarter
|
|
1882
AAR Corp
AIR
$3.91B
| $280K | ﹤0.01% |
+1,958
| New | +$231K |
2026 Q2
0 quarters
|
|
1883
Sound Financial Bancorp
SFBC
$116M
| $278K | ﹤0.01% |
6,450
| – | – |
2023 Q2
12 quarters
|
|
1884
Cogent Biosciences
COGT
$5.36B
| $278K | ﹤0.01% |
7,176
+716
| +11% | +$25.1K |
2026 Q1
1 quarter
|
|
1885
Protagonist Therapeutics
PTGX
$9.08B
| $278K | ﹤0.01% |
2,264
-57
| -2% | -$5.95K |
2026 Q1
1 quarter
|
|
1886
Fulgent Genetics
FLGT
$556M
| $276K | ﹤0.01% |
+13,446
| New | +$228K |
2026 Q2
0 quarters
|
|
1887
Hexcel
HXL
$6.04B
| $275K | ﹤0.01% |
2,751
-1,375
| -33% | -$125K |
2026 Q1
1 quarter
|
|
1888
Kirby Corp
KEX
$7.11B
| $275K | ﹤0.01% |
2,024
-92
| -4% | -$13.2K |
2026 Q1
1 quarter
|
|
1889
Core Scientific
CORZ
$4.34B
| $275K | ﹤0.01% |
10,751
-12,344
| -53% | -$291K |
2026 Q1
1 quarter
|
|
1890
DELISTED
Apogee Therapeutics
APGE
| $274K | ﹤0.01% |
+2,065
| New | +$186K |
2026 Q2
0 quarters
|
|
1891
Avnet
AVT
$7.37B
| $272K | ﹤0.01% |
3,064
-3,769
| -55% | -$308K |
2026 Q1
1 quarter
|
|
1892
Greif Class B
GEF.B
$4.35B
| $271K | ﹤0.01% |
2,901
| – | – |
2026 Q1
1 quarter
|
|
1893
Hims & Hers Health
HIMS
$6.44B
| $271K | ﹤0.01% |
+7,814
| New | +$210K |
2026 Q2
0 quarters
|
|
1894
HUB Group
HUBG
$1.59B
| $270K | ﹤0.01% |
6,170
-21
| -0.3% | -$881 |
2026 Q1
1 quarter
|
|
1895
Greif
GEF
$4.7B
| $270K | ﹤0.01% |
3,627
-475
| -12% | -$31.9K |
2026 Q1
1 quarter
|
|
1896
Lantheus
LNTH
$6.52B
| $270K | ﹤0.01% |
2,434
-9,545
| -80% | -$889K |
2026 Q1
1 quarter
|
|
1897
Antero Midstream
AM
$9.9B
| $269K | ﹤0.01% |
11,833
-13,065
| -52% | -$284K |
2023 Q1
13 quarters
|
|
1898
Kyndryl
KD
$3.2B
| $269K | ﹤0.01% |
+23,757
| New | +$296K |
2026 Q2
0 quarters
|
|
1899
Kymera Therapeutics
KYMR
$9.5B
| $268K | ﹤0.01% |
2,338
-100
| -4% | -$8.59K |
2026 Q1
1 quarter
|
|
1900
Starwood Property Trust
STWD
$4.64B
| $265K | ﹤0.01% |
16,161
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
Empowered Funds's Q2 2026 Portfolio in Review
As of Q2 2026, Empowered Funds held 2,320 positions worth $19B, up 21% from $15.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Empowered Funds deployed $1.12B of net new capital in Q2 2026, opening 218 new positions and adding to 1,053 existing holdings. Its largest new stake was Invesco QQQ Trust: 83,446 shares worth $61.4M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $41M trimmed.
- Empowered Funds's largest Q2 2026 buy was Invesco QQQ Trust: 83,446 shares worth $61.4M.
- Empowered Funds added most to TSMC in Q2 2026, an estimated $264M increase.
- Empowered Funds's biggest Q2 2026 reduction was Microsoft, cutting an estimated $41M.
- Empowered Funds fully exited GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF in Q2 2026, selling an estimated $26.4M.
- Empowered Funds's ten largest holdings make up 17% of its $19B portfolio in Q2 2026.
- Empowered Funds opened 218 new positions and closed 208 in Q2 2026.
- Empowered Funds's portfolio value rose 21% quarter-over-quarter to $19B.
Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.